Analysts Viewpoint
Stoke Therapeutics Inc (STOK) rating initates by Jefferies
Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $0.11 million
Menu
Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $0.11 million
In a filing, Stoke Therapeutics Inc revealed its Director EDWARD M KAYE acquired Company’s shares for reported $1.22 million on
In a filing, Stoke Therapeutics Inc revealed its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $51158.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Stoke Therapeutics
Stoke Therapeutics Inc’s recently made public that its GENERAL COUNSEL & CORP SEC Allan Jonathan unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $57724.0 on
In a filing, Stoke Therapeutics Inc revealed its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $57724.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its